Skip to main content
SpringerLink
Log in

The effect of VAV3 polymorphisms on thyroid cancer

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Background

The incidence of thyroid cancer is rising rapidly in China, but there are few studies on the risk factors of thyroid cancer in the Chinese Han population.

Methods

We performed this case–control study of 510 patients and 509 controls to for determine the linkage of VAV3 variants (rs17019602, rs7521681, rs4915076, and rs1777451) with thyroid cancer susceptibility by computing the odds ratio (OR) and 95% confidence intervals (CI). Multi-factor dimension reduction (MDR) analysis was conducted to assess interaction of VAV3 genetic variants.

Results

We found that rs7521681 was remarkably related to a higher risk of thyroid cancer (OR = 1.74, p = 0.012), whereas rs4915076 (OR = 0.66, p = 0.001) significantly decreased thyroid cancer susceptibility. Stratified analyses showed that rs4915076 had a protective role in thyroid cancer in both ages >45 years (OR = 0.70, p = 0.017) and age ≤45 years (OR = 0.63, p = 0.007). Rs17019602 could increase the susceptibility of thyroid cancer in men (OR = 4.76, p = 0.049). Rs7521681 was related to an increased risk of thyroid cancer in women (OR = 1.97, p = 0.012). Rs4915076 could protect individuals from thyroid cancer both in men (OR = 0.60, p = 0.031) and women (OR = 0.68, p = 0.010). Moreover, rs4915076 was the best single-locus model to predict thyroid cancer. Interestingly, the interaction model of rs17019602, rs7521681, rs4915076, rs1777451, and age was a candidate gene-environment model.

Conclusion

Our results indicated VAV3 variants were associated with thyroid cancer, which provides a new sight into etiology of thyroid cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. W.R. Burns, M.A. Zeiger, Differentiated thyroid cancer. Seminars in Oncology 37, 557–566 (2010)

    Article  CAS  Google Scholar 

  2. J. Jonklaas et al. The impact of age and gender on papillary thyroid cancer survival. J. of Clin. Endocrinol. & Metab 6, 878–887 (2012)

    Article  Google Scholar 

  3. Y.Q. Liu, S.Q. Zhang, W.Q. Chen, L.L. Chen, R.S. Zheng, [Trend of incidence and mortality on thyroid cancer in China during 2003 - 2007]. Zhonghua Liu Xing Bing Xue Za Zhi 33, 1044–1048 (2012)

    PubMed  Google Scholar 

  4. D. Schmid, G. Behrens, C. Jochem, M. Keimling, M. Leitzmann, Physical activity, diabetes, and risk of thyroid cancer: a systematic review and meta-analysis. European journal of epidemiology 28, 945–958 (2013). https://doi.org/10.1007/s10654-013-9865-0

    Article  PubMed  Google Scholar 

  5. H. Arem, E. Loftfield Cancer epidemiology: a survey of modifiable risk factors for prevention and survivorship. Am. j. of lifestyle med. 12, 200–210 (2018). https://doi.org/10.1177/1559827617700600

    Article  Google Scholar 

  6. J. Kim, J.E. Gosnell, S.A. Roman, Geographic influences in the global rise of thyroid cancer. 16, 17–29, https://doi.org/10.1038/s41574-019-0263-x (2020)

  7. H.Y. Son et al. Genome-wide association and expression quantitative trait loci studies identify multiple susceptibility loci for thyroid cancer. Nat. Commun. 8, 15966 (2017)

    Article  CAS  Google Scholar 

  8. W. Zhou, & B. Brumpton, GWAS of thyroid stimulating hormone highlights pleiotropic effects and inverse association with thyroid cancer. 11, 3981, https://doi.org/10.1038/s41467-020-17718-z (2020)

  9. S.S. Song, S. Huang, S. Park, Association of polygenetic risk scores related to cell differentiation and inflammation with thyroid cancer risk and genetic interaction with dietary intake. 13, https://doi.org/10.3390/cancers13071510 (2021)

  10. L. Zeng, P. Sachdev, L. Yan, J.L. Chan, L.H. Wang, Vav3 mediates receptor protein tyrosine kinase signaling, regulates gtpase activity, modulates cell morphology, and induces cell transformation. Mol. & Cell. Biol. 20, 9212–9224 (2001)

    Article  Google Scholar 

  11. K.-T. Lin et al. Vav3-Rac1 signaling regulates prostate cancer metastasis with elevated Vav3 expression correlating with prostate cancer progression and posttreatment recurrence. Cancer Res. 72, 3000–3009 (2012)

    Article  CAS  Google Scholar 

  12. H. Aguilar et al. VAV3 mediates resistance to breast cancer endocrine therapy. Breast Cancer Res. 16, 53–69 (2014)

  13. G. Riesco-Eizaguirre, P. Santisteban, New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy. Endocrine Rel. Cancer 14, 957–977 (2008)

    Article  Google Scholar 

  14. N. Perretta-Tejedor et al. Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors. Sci. Rep. 7, 41875 (2017)

    Article  CAS  Google Scholar 

  15. M. Liu, N. Miao, Y. Zhu, C.Y. Gu, Q.X. Li, Association between polymorphism in Vav3 genes and risk of primary prostatic cancer in Chinese Han population. Zhonghua bing li xue za zhi Chinese j. of pathol. 45, 451–456 (2016)

    CAS  Google Scholar 

  16. R. Usategui-Martín, I. Calero-Paniagua, J. García-Aparicio, L. Corral-Gudino, R.G. Sarmiento, VAV3 gene polymorphism is associated with Paget’s disease of bone. Genetic Testing & Mol. Biomarkers 20, 335–337 (2016)

    Article  Google Scholar 

  17. G. Palomba et al. Genome-wide association study of susceptibility loci for breast cancer in Sardinian population. Bmc Cancer 15, 383 (2015)

    Article  Google Scholar 

  18. D. Liu, Z.G. Zhao, Z.L. Jiao, H.J. Li, Identifying differential expression genes and single nucleotide variations using RNA-seq in metastatic melanoma. Genetics & Molecular Research Gmr 13, 8153–8162 (2014)

    Article  CAS  Google Scholar 

  19. C. Wu, G. Li, W. Li, The interaction effect of rs4077515 and rs17019602 increases the susceptibility to IgA nephropathy. Oncotarget 8, 76492–76497 (2017)

    Article  Google Scholar 

  20. O. Daisuke et al. Identification of a Hashimoto Thyroiditis susceptibility locus via a genome-wide comparison with Graves' disease. J. of Clin. Endocrinol. & Metab 2, 319–324 (2015)

    Google Scholar 

  21. N. Horita, T. Kaneko, Genetic model selection for a case-control study and a meta-analysis. Meta gene 5, 1–8 (2015). https://doi.org/10.1016/j.mgene.2015.04.003

    Article  PubMed  PubMed Central  Google Scholar 

  22. A. et al. Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors. ACC Current J. Rev. 42, 1429–1437 (2004)

  23. H. Aguilar et al. VAV3 mediates resistance to breast cancer endocrine therapy. Breast Cancer Res. 16, 1–16 (2014).

  24. Y.H. Uen et al. VAV3 oncogene expression in colorectal cancer: Clinical aspects and functional characterization. Scientific Reports 5, 9360 (2015)

    Article  CAS  Google Scholar 

  25. M. Xie et al. The long intergenic non-protein coding RNA 707 promotes proliferation and metastasis of gastric cancer by interacting with mRNA stabilizing protein HuR. Cancer Letters 68, 67–79 (2018)

    Google Scholar 

  26. S. Kwak et al. A genome-wide association study on thyroid function and anti-thyroid peroxidase antibodies in Koreans. Human mol. genet. 23, 4433–4442 (2014). https://doi.org/10.1093/hmg/ddu145

    Article  CAS  Google Scholar 

  27. N. Eriksson et al. Novel associations for hypothyroidism include known autoimmune risk loci. PloS one 7, e34442 (2012). https://doi.org/10.1371/journal.pone.0034442

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We sincerely thank all participators in the study.

Author information

Author notes

  1. These authors contributed equally: Wanli Ren, Chongwen Xu

Authors and Affiliations

  1. Otorhinolaryngology head and neck surgery, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, 710061, China

    Wanli Ren, Chongwen Xu, Shiyang Wang, Huajing Li, Hao Dai, Fangli Yang, Yuan Shao & Yanxia Bai

Authors
  1. Wanli Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chongwen Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shiyang Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Huajing Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hao Dai
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fangli Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yuan Shao
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yanxia Bai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Yuan Shao or Yanxia Bai.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ren, W., Xu, C., Wang, S. et al. The effect of VAV3 polymorphisms on thyroid cancer. Endocrine 75, 178–184 (2022). https://doi.org/10.1007/s12020-021-02827-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-021-02827-6

Keywords

Search

Navigation